{"version":"1.0","provider_name":"The Medical Xchange","provider_url":"https:\/\/themedicalxchange.com\/en\/","title":"Challenges in the Management of Pediatric IBD: Expanding Treatment Options - The Medical Xchange","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"bIpsQXuWrQ\"><a href=\"https:\/\/themedicalxchange.com\/en\/2014\/09\/23\/3rd-international-symposium-on-pediatric-inflammat\/\">Challenges in the Management of Pediatric IBD: Expanding Treatment Options<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/themedicalxchange.com\/en\/2014\/09\/23\/3rd-international-symposium-on-pediatric-inflammat\/embed\/#?secret=bIpsQXuWrQ\" width=\"600\" height=\"338\" title=\"&#8220;Challenges in the Management of Pediatric IBD: Expanding Treatment Options&#8221; &#8212; The Medical Xchange\" data-secret=\"bIpsQXuWrQ\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script>\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/themedicalxchange.com\/wp-includes\/js\/wp-embed.min.js\n<\/script>\n","thumbnail_url":"https:\/\/themedicalxchange.com\/wp-content\/uploads\/2014\/09\/2345_PiBD_2014_EN_Fig_1.PNG","thumbnail_width":960,"thumbnail_height":720,"description":"Rotterdam \u2013 In Canada, as elsewhere, the incidence of inflammatory bowel disease (IBD) has been rising significantly in children and adolescents, particularly in children aged under 10 years (Crohn's and Colitis Foundation of Canada, 2012). Children and adolescents with IBD have more extensive and severe disease, need more comprehensive work-up and require more aggressive treatment than adults. They also face the possibility of growth problems and pubertal delay.Results presented at this year\u2019s PiBD conference showed improvement in growth with anti-TNF therapy, as well, similar response and remission rates were observed regardless of immunotherapy use at baseline. Close monitoring of fecal calprotectin to better predict relapse and considering earlier anti-TNF treatment to achieve remission is an important step forward in IBD care."}